Skin, Hair, and Nail Care with News

Posts for: March, 2017

Dr. Jonathan Schreiber, PhD is relieved to report a "great, new treatment" for his moderate-to-severe Eczema (Atopic Dermatitis) patients with Dupixent (dupilumab), the FDA's new biologic injection announced today.  Research has shown psoriasis's immune-driven model can be applied to reverse Eczema, click images to connect to Dr. Emma Guttman-Yassky, MD, PhD speech at the American Academy of Dermatology event.

Taking Care of Tidewater ~ See the Difference with Us!

Emma Guttman-Yassky, MD, PhD: “This is proof the disease is reversible, an immune-driven disease, like psoriasis. This is a game-changer and a life-changer.”

 

March 25, 2017
Category: Home
Tags: Untagged

Pets need zinc-free sunscreen due toxicity, one for human babies or sensitive skin will safe, check label!

FDA warns pet owners on Fluorouracil, the proven skin-cancer cream in cases of squamous cell carcinoma and basal cell carcinoma, Dr. Tom Rohrer, a dermatologic surgeon and board member of national organizations including the American Society for Dermatologic Surgery said the drug is "a very safe, very effective medication that prevents skin cancer and stops pre-cancerous skin before they become skin cancer.  We will have to make special recommendations to keep it away from pets and to wash their hands before petting their pets."  FDA recommends patients safely discard or clean any cloths or applicators used when applying the cream. It's also important to make sure clothes, carpets, floors and furniture contain no creamy residue. Hands must also be cleaned after using the cream, read full article details here.
 
 

 


March 24, 2017
Category: Home
Tags: Untagged

Today's approval of avelumab by the US Food and Drug Administration (FDA) is the first for a treatment of Merkel cell carcinoma (MCC), a rare and aggressive form of skin cancer.  "While skin cancer is one of the most common cancers, MCC patients have not had an approved treatment option until now," said Richard Pazdur, MD, acting director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research and director of the FDA's Oncology Center of Excellence, read full article here.

Taking Care of Tidewater ~ See the Difference with Us! 

 

 


After immunization, the protection lasts for years providing pain relief for all ages, click here to read the article from HealthDay.  Click any image to be connected to Online Scheduling for Dr. Jonathan Schreiber, Taking Care of Tidewater ~ See the Difference with Us!

 


March 23, 2017
Category: Home
Tags: Costenyx   ZocDoc  

Novartis’ cutting-edge psoriasis treatment Cosentyx, continues to stand apart with ground-breaking results for long-term patient relief, read article here.  

Taking Care of Tidewater ~ See the Difference with Us!